This company has been acquired
RCM Stock Overview
Provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for RCM from our risk checks.
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
R1 RCM Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$14.31 |
| 52 Week High | US$15.12 |
| 52 Week Low | US$8.87 |
| Beta | 0.84 |
| 1 Month Change | 0.49% |
| 3 Month Change | 1.63% |
| 1 Year Change | 33.36% |
| 3 Year Change | -43.15% |
| 5 Year Change | 10.76% |
| Change since IPO | 5.61% |
Recent News & Updates
Shareholder Returns
| RCM | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0.07% | -0.7% | 1.3% |
| 1Y | 33.4% | -11.2% | 8.2% |
Return vs Industry: RCM exceeded the US Healthcare industry which returned 3% over the past year.
Return vs Market: RCM exceeded the US Market which returned 29.7% over the past year.
Price Volatility
| RCM volatility | |
|---|---|
| RCM Average Weekly Movement | 0.3% |
| Healthcare Industry Average Movement | 7.8% |
| Market Average Movement | 7.9% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 4.1% |
Stable Share Price: RCM has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: RCM's weekly volatility has decreased from 6% to 0% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 29,650 | Lee Rivas | www.r1rcm.com |
R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance.
R1 RCM Inc. Fundamentals Summary
| RCM fundamental statistics | |
|---|---|
| Market cap | US$6.04b |
| Earnings (TTM) | -US$61.20m |
| Revenue (TTM) | US$2.46b |
2.5x
P/S Ratio-98.8x
P/E RatioIs RCM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RCM income statement (TTM) | |
|---|---|
| Revenue | US$2.46b |
| Cost of Revenue | US$1.99b |
| Gross Profit | US$472.70m |
| Other Expenses | US$533.90m |
| Earnings | -US$61.20m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.14 |
| Gross Margin | 19.19% |
| Net Profit Margin | -2.48% |
| Debt/Equity Ratio | 78.6% |
How did RCM perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/11/20 00:09 |
| End of Day Share Price | 2024/11/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
R1 RCM Inc. is covered by 27 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vikram Kesavabhotla | Baird |
| Michael Cherny | BofA Global Research |
| Bret Jones | Brean Capital |